The VPAP Adapt is indicated for the treatment of patients weighing more than 66 lb (30 kg) with obstructive sleep apnea (OSA), central and/or mixed apneas, or periodic breathing. It is intended for home and hospital use.

Device Description

VPAP Adapt System (VPAP Adapt with H5) is similar to the predicate device(s), using a blower based positive pressure system with an integrated heated humidfier and heater controller. The device platform is identical to the S9 VPAP Adapt (K102586) and contains a Micro-processor controlled blower system that generates controlled positive airway pressure between 3-25 cmHzO as required to maintain an "air splint" for effective treatment of OSA. The system comprises the flow generator, patient interface) and humidifier.

The VPAP Adapt is a flow generator device designed to provide adaptive servo-ventilation therapy (ASV) to stabilize a patient's ventilation during sleep. The device continually measures the patient's instantaneous ventilation, and calculates a target ventilation based on to the patient's recent average. It then adjusts the degree of pressure support to servo-control the patient's ventilation to at least equal the target ventilation. Therapy modes contained in the VPAP Adapt are CPAP, ASV, and ASVAuto. CPAP and ASV therapy modes come from the S9 VPAP Adapt (K102586).

The functional characteristics of the VPAP Adapt system includes all the clinician and user friendly features of the predicate device.

AI/ML Overview

The provided text is a 510(k) summary for the ResMed VPAP Adapt device, a non-continuous ventilator. The document focuses on demonstrating substantial equivalence to a predicate device rather than providing a detailed study of the device's performance against specific acceptance criteria in a clinical setting.

Based on the information provided, here's a breakdown of the requested points:

Device: VPAP Adapt (Non-continuous ventilator)

1. Table of Acceptance Criteria and Reported Device Performance

The document does not provide a table of clinical acceptance criteria (e.g., AHI reduction, oxygen saturation improvement) with corresponding device performance metrics. Instead, it refers to "predetermined acceptance criteria" for bench testing demonstrating the ASVAuto algorithm's specification and the device's adherence to safety and performance standards.

Acceptance Criteria Category	Specific Criteria (as described)	Reported Device Performance	Study Type
ASVAuto Algorithm Performance	"Performs to specification"	"Demonstrated that the VPAP Adapt met the predetermined pass/fail criteria"	Bench Testing
EPAP Response	"EPAP response tests to Flow Limitation, Snore and Apnea events"	"Demonstrated that the VPAP Adapt met the predetermined pass/fail criteria"	Bench Testing
Safety and Essential Performance	Compliance with IEC 60601-1:2005 (General requirements for safety)	"passed all test protocols"	Standards Testing
Electromagnetic Compatibility (EMC)	Compliance with IEC 60601-1-2:2007 (EMC requirements)	"passed all test protocols"	Standards Testing

2. Sample Size Used for the Test Set and Data Provenance

Test Set Sample Size: Not applicable. The "tests" mentioned are bench tests using "closed-loop and open-loop test scripts from patient models," not human subjects or a clinical test set. Therefore, there's no patient sample size.
Data Provenance: Not applicable, as no clinical data from human subjects is mentioned for the verification activities. The "patient models" used in bench testing would be simulated data or hardware models.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

Not applicable. The "ground truth" for the bench tests was based on the device's own specifications and the performance of the predicate device (S9 VPAP Adapt K102586). No human experts were used to establish ground truth for a test set in the clinical sense.

4. Adjudication Method for the Test Set

Not applicable. There was no clinical test set requiring human adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly mentioned or conducted. The document focuses on demonstrating substantial equivalence through bench testing to a predicate device, not on comparing human reader performance with and without AI assistance.

6. Standalone (Algorithm Only) Performance Study

Yes, in a way. The "Non-Clinical Testing" section describes "extensive bench testing using both closed-loop and open-loop test scripts from patient models designed to verify that the ASVAuto algorithm in the VPAP Adapt performs to specification." This is a form of standalone testing of the algorithm within the device against preset criteria. It's not a clinical standalone study, but an engineering verification.

7. Type of Ground Truth Used for the Testing

The ground truth for the bench testing was the design specification of the ASVAuto algorithm and the performance characteristics of the predicate device (S9 VPAP Adapt K102586). It's based on engineering requirements and existing device performance, not clinical pathology, expert consensus, or outcomes data from human subjects.

8. Sample Size for the Training Set

Not applicable. The document does not describe any machine learning training processes or a "training set" in the context of AI. The device's algorithm appears to be rule-based or pre-programmed, not learned from a dataset.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as no training set is mentioned for an AI/machine learning model. The algorithm's behavior is described as "continually measures the patient's instantaneous ventilation, and calculates a target ventilation based on to the patient's recent average. It then adjusts the degree of pressure support to servo-control the patient's ventilation." This implies a deterministic, pre-defined control algorithm, not one developed through machine learning.

Summary

{0}------------------------------------------------

MAY 2 5 2012

以 1173801 510(k) Summary - VPAP Adapt

Date Prepared 20₪ Dec, 2011 Submitter Greg Dockar Senior Regulatory Affairs Manager

Official Contact

Mr David D'Cruz – V.P., US Medical & Regulatory Affairs ResMed Corp. 9001 Spectrum Center Boulevard, San Diego, CA 92123

Tel: (858) 836-5984

Classification Reference

21 CFR 868.5905

Product Code

73 BZD

Common/Usual Name

Non continuous ventilator (IPPB).

Proprietary Name

VPAP Adapt

Predicate Device(s)

S9 VPAP Adapt (K102586)

Reason for submission

New Device

{1}------------------------------------------------

Indication for Use

Substantial Equivalence

The new device has the following similarities to the previously cleared predicate devices.

Same intended use
A Same operating principle
Similar technologies
Same manufacturing process >

Design and Verification activities were performed on the VPAP Adapt System as a result of the risk and design requirements. All tests (predicate bench testing) confirmed the product met the predetermined acceptance criteria. ResMed has determined that the new device has not altered the safety and effectiveness of CPAP/Bilevel treatment for patients with Obstructive Sleep Apnoea (OSA), central and/or mixed apneas, or periodic breathing who weigh more than 66 lb (>30 kg). The new device complies with the applicable requirements referenced in the FDA guidance documents:

FDA Reviewer Guidance for Premarket Notification Submissions (November 1993) A
FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices > (May 11, 2005)

Standards Testing:

The VPAP Adapt has been tested to appropriate FDA consensus standards and other applicable requirements passing all test protocols. The VPAP Adapt with and without the integrated heated humidifier (H5)) was designed and tested according to:

IEC 60601-1-2:2007. Medical electrical equipment Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests
IEC 60601-1:2005, Medical electrical equipment Part 1: General requirements for safety Medical electrical equipment - General requirements for basic safety and essential performance

Non-Clinical Testing

Predicate bench testing was used to show substantial equivalence between the S9 VPAP Adapt (K102586), and the VPAP Adapt.

ResMed conducted extensive bench testing using both closed-loop and open-loop test scripts from patient models designed to verify that the ASVAuto algorithm in the VPAP Adapt performs to specification. These tests included Adaptive servo-ventilation tests for the ASV functionality, and EPAP response tests to Flow Limitation, Snore and Apnea events for the auto-adjusting EPAP component. The bench test results demonstrated that the VPAP Adapt met the predetermined pass/fail criteria.

Device Description

{2}------------------------------------------------

The functional characteristics of the VPAP Adapt system includes all the clinician and user friendly features of the predicate device.

Conclusion

The VPAP Adapt is substantially equivalent to the Predicate device, S9 VPAP Adapt (K102586)

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Mr. David D'Cruz Vice President US Medical & Regulatory Affairs ResMed Corporation 9001 Spectrum Center Boulevard Kearny Mesa, California 92123

MAY 2 5 2012

Re: K113801 Trade/Device Name: VPAP ADAPT

Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: May 22, 2012 Received: May 24, 2012

Dear Mr. D'Cruz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2- Mr. D'Cruz

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

ph fac

Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indication for Use

510(k) Number (if known):

Device Name: VPAP Adapt

Indication for Use

Prescription Use __ X________ AND/OR

Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________

(Part 21 CFR 801 Subpart D)

(Part 21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH; Office of Device Evaluation (ODE)

Page 1 of__1_

(Division Sign-Off)

Division of Anesthesiology, General Hospital infection Control, Dental Devices

510(k) Number: _ 41138801 .
در

Regulation Number and Section

§ 868.5905 Noncontinuous ventilator (IPPB).

(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).